Evidence map›Paper›PMID 26275606›Full record

ArticleMolecular neurodegeneration2015

STIM2 protects hippocampal mushroom spines from amyloid synaptotoxicity.

Elena Popugaeva, Ekaterina Pchitskaya, Anastasiya Speshilova, Sergey Alexandrov, Hua Zhang, Olga Vlasova, Ilya Bezprozvanny

Open access · goldAbstract read
In one paragraph

Article in Molecular neurodegeneration, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Elena PopugaevaLaboratory of Molecular Neurodegeneration, Department of Medical Physics, Peter the Great St.Petersburg Polytechnic University, St. Petersburg, Russian Federation. lena.popugaeva@gmail.com.
Ekaterina PchitskayaLaboratory of Molecular Neurodegeneration, Department of Medical Physics, Peter the Great St.Petersburg Polytechnic University, St. Petersburg, Russian Federation. katrincreative@yandex.ru.
Anastasiya SpeshilovaLaboratory of Microscopy and Microanalysis, Department of Physics-chemistry and Microsystem Technique, Institute of Metallurgy, Mechanical Engineering and Transport, Peter the Great St.Petersburg Polytechnic University, St. Petersburg, Russian Federation. speshaab@yandex.ru.
Sergey AlexandrovLaboratory of Microscopy and Microanalysis, Department of Physics-chemistry and Microsystem Technique, Institute of Metallurgy, Mechanical Engineering and Transport, Peter the Great St.Petersburg Polytechnic University, St. Petersburg, Russian Federation. salexsandrov@spbstu.ru.
Hua ZhangDepartment of Physiology, UT Southwestern Medical Center at Dallas, Dallas, TX, 75390, USA. hua.zhang@utsouthwestern.edu.
Olga VlasovaLaboratory of Molecular Neurodegeneration, Department of Medical Physics, Peter the Great St.Petersburg Polytechnic University, St. Petersburg, Russian Federation. olvlasova@yandex.ru.
Ilya BezprozvannyLaboratory of Molecular Neurodegeneration, Department of Medical Physics, Peter the Great St.Petersburg Polytechnic University, St. Petersburg, Russian Federation. ilya.bezprozvanny@utsouthwestern.edu.
Peter the Great St. Petersburg Polytechnic University · RUSouthwestern Medical CenterSouthwestern Medical Center · US

Funding

Presenilins and neuronal calcium dyshomeostasisR01NS080152 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI BEZPROZVANNY, ILYA B · 2013 to 2017
$2.3M
NINDS NIH HHS R01 NS080152NINDS NIH HHS R01NS080152
6 · The paper itself

Abstract

backgroundAlzheimer disease (AD) is a disease of lost memories. Mushroom postsynaptic spines play a key role in memory storage, and loss of mushroom spines has been proposed to be linked to memory loss in AD. Generation of amyloidogenic peptides and accumulation of amyloid plaques is one of the pathological hallmarks of AD. It is important to evaluate effects of amyloid on stability of mushroom spines.

resultsIn this study we used in vitro and in vivo models of amyloid synaptotoxicity to investigate effects of amyloid peptides on hippocampal mushroom spines. We discovered that application of Aβ42 oligomers to hippocampal cultures or injection of Aβ42 oligomers directly into hippocampal region resulted in reduction of mushroom spines and activity of synaptic calcium-calmodulin-dependent kinase II (CaMKII). We further discovered that expression of STIM2 protein rescued CaMKII activity and protected mushroom spines from amyloid toxicity in vitro and in vivo.

conclusionsObtained results suggest that downregulation of STIM2-dependent stability of mushroom spines and reduction in activity of synaptic CaMKII is a mechanism of hippocampal synaptic loss in AD model of amyloid synaptotoxicity and that modulators/activators of this pathway may have a potential therapeutic value for treatment of AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsCA1 Region, HippocampalCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCells, CulturedDendritesGene Expression RegulationGenes, ReporterGenes, SyntheticGenetic VectorsHumansInjectionsMembrane GlycoproteinsMiceAmyloid beta-Peptidesamyloid beta-protein (1-40)amyloid beta-protein (1-42)Calcium-Calmodulin-Dependent Protein Kinase Type 2Membrane GlycoproteinsNerve Tissue ProteinsPeptide FragmentsRecombinant Fusion ProteinsStim2 protein, mouseStromal Interaction Molecule 2

Identifiers

PMID26275606
PMCPMC4536802
OpenAlexW2118518058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.